MedRhythms

CompanyUnited States

MedRhythms develops one asset, in human trials (MR-001 in chronic stroke). Mostly device; based in the United States.

1
Asset
Furthest stage
Human trials
1
Trial
1
Signal

Pipeline

1
  • MR-001

    Digitally delivers rhythmic auditory stimulation to improve walking speed after stroke.

    Human trials, Device, chronic stroke

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals1

Intelligence